|
1
|
Qureshi AI, Mendelow AD and Hanley DF:
Intracerebral haemorrhage. Lancet. 373:1632–1644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Asch CJ, Luitse MJ, Rinkel GJ, van der
Tweel I, Algra A and Klijn CJ: Incidence, case fatality, and
functional outcome of intracerebral haemorrhage over time,
according to age, sex, and ethnic origin: A systematic review and
meta-analysis. Lancet Neurol. 9:167–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zahuranec DB, Lisabeth LD, Sánchez BN,
Smith MA, Brown DL, Garcia NM, Skolarus LE, Meurer WJ, Burke JF,
Adelman EE and Morgenstern LB: Intracerebral hemorrhage mortality
is not changing despite declining incidence. Neurology.
82:2180–2186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xi G, Strahle J, Hua Y and Keep RF:
Progress in translational research on intracerebral hemorrhage: Is
there an end in sight? Prog Neurobiol. 115:45–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Wang Y, Wang J, Stetler Anne R and
Yang QW: Inflammation in intracerebral hemorrhage: From mechanisms
to clinical translation. Prog Neurobiol. 115:25–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendelow AD, Gregson BA, Fernandes HM,
Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD and Barer DH:
STICH investigators: Early surgery versus initial conservative
treatment in patients with spontaneous supratentorial intracerebral
haematomas in the International Surgical Trial in Intracerebral
Haemorrhage (STICH): A randomised trial. Lancet. 365:387–397. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aronowski J and Zhao X: Molecular
pathophysiology of cerebral hemorrhage: Secondary brain injury.
Stroke. 42:1781–1786. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J: Preclinical and clinical research
on inflammation after intracerebral hemorrhage. Prog Neurobiol.
92:463–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kong Y and Le Y: Toll-like receptors in
inflammation of the central nervous system. Int Immunopharmacol.
11:1407–1414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YC, Zhou Y, Fang H, Lin S, Wang PF,
Xiong RP, Chen J, Xiong XY, Lv FL, Liang QL and Yang QW: Toll-like
receptor 2/4 heterodimer mediates inflammatory injury in
intracerebral hemorrhage. Ann Neurol. 75:876–889. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang S, Zou J, Li P, Zheng X and Feng D:
Curcumin protects against atherosclerosis in apolipoprotein
E-knockout mice by inhibiting toll-like receptor 4. expression. J
Agr Food Chem. 66:449–456. 2018. View Article : Google Scholar
|
|
13
|
Yao L, Shi Y, Zhao X, Hou A, Xing Y, Fu J
and Xue X: Vitamin D attenuates hyperoxia-induced lung injury
through downregulation of Toll-like receptor 4. Int J Mol Med.
39:1403–1408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang Q, Wu Q, Jiang J, Duan J, Wang C,
Smith MD, Lu H, Wang Q, Nagarkatti P and Fan D: Characterization of
sparstolonin B, a Chinese herb-derived compound, as a selective
Toll-like receptor antagonist with potent anti-inflammatory
properties. J Biol Chem. 286:26470–26479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang QL, Lei LL, Cui X, Zou NS and Duan
JA: Bioactive cis-stilbenoids from the tubers of Scirpus yagara.
Fitoterapia. 84:170–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong Q, Zhou K, Liang QL, Lin S, Wang YC,
Xiong XY, Meng ZY, Zhao T, Zhu WY, Yang YR, et al: Interleukin-23
secreted by activated macrophages drives γδT cell production of
interleukin-17 to aggravate secondary injury after intracerebral
hemorrhage. J Am Heart Assoc. 5:e0043402016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kilkenny C, Browne WJ, Cuthill IC, Emerson
M and Altman DG: Improving bioscience research reporting: The
ARRIVE guidelines for reporting animal research. PLoS Biol.
8:e10004122010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vorhees CV and Williams MT: Value of water
mazes for assessing spatial and egocentric learning and memory in
rodent basic research and regulatory studies. Neurotoxicol Teratol.
45:75–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Terry AV Jr: Spatial navigation (Water
Maze) tasksMethods of behavior analysis in neuroscience. 2nd
edition. Buccafusco JJ: Boca Raton (FL): 2009
|
|
20
|
Wang YC, Wang PF, Fang H, Chen J, Xiong XY
and Yang QW: Toll-like receptor 4 antagonist attenuates
intracerebral hemorrhage-induced brain injury. Stroke.
44:2545–2552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao X, Zhang Y, Strong R, Grotta JC and
Aronowski J: 15d-Prostaglandin J2 activates peroxisome
proliferator-activated receptor-gamma, promotes expression of
catalase, and reduces inflammation, behavioral dysfunction, and
neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood
Flow Metab. 26:811–820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin S, Yin Q, Zhong Q, Lv FL, Zhou Y, Li
JQ, Wang JZ, Su BY and Yang QW: Heme activates TLR4-mediated
inflammatory injury via MyD88/TRIF signaling pathway in
intracerebral hemorrhage. J Neuroinflamm. 9:462012. View Article : Google Scholar
|
|
23
|
Chang CF, Chen SF, Lee TS, Lee HF and
Shyue SK: Caveolin-1 deletion reduces early brain injury after
experimental intracerebral hemorrhage. Am J Pathol. 178:1749–1761.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Belur PK, Chang JJ, He S, Emanuel BA and
Mack WJ: Emerging experimental therapies for intracerebral
hemorrhage: Targeting mechanisms of secondary brain injury.
Neurosurg Focus. 34:E92013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ziai WC: Hematology and inflammatory
signaling of intracerebral hemorrhage. Stroke. 44 6 Suppl
1:S74–S78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang Q, Dong S, Lei L, Liu J, Zhang J, Li
J, Duan J and Fan D: Protective effects of Sparstolonin B, a
selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
Cytokine. 75:302–309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Q, Wang J, Liang Q, Wang D, Luo Y, Li
J, Janicki JS and Fan D: Sparstolonin B attenuates
hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol
Med (Maywood). 239:376–384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao Y, Guan K, He X, Wei CW, Zheng ZR,
Zhang YH, Ma SL, Zhong H and Shi W: Yersinia YopJ negatively
regulates IRF3-mediated antibacterial response through disruption
of STING-mediated cytosolic DNA signaling. Biochim Biophys Acta.
1863:3148–3159. 2016. View Article : Google Scholar : PubMed/NCBI
|
